Cite

HARVARD Citation

    Vazquez-Espinosa, E. et al. (2016). Tobramycin inhalation powder (TOBI Podhaler®) for the treatment of lung infection in patients with cystic fibrosis. Expert review of anti-infective therapy. 14 (1), pp. 9-17. [Online]. 
  
Back to record